5%, and the prevalence of HCC in NASH to be 0%-28% over time per

5%, and the prevalence of HCC in NASH to be 0%-2.8% over time periods of up to 19.5 years43, 46-48 (Table 1). The development of cirrhosis in NASH typically occurs at an older age than in other liver diseases, although once cirrhosis does develop in patients with NASH,

their clinical course is comparable to patients with other causes of cirrhosis.40, selleck chemicals llc 44 NASH has been proposed as a probable cause of idiopathic or cryptic cirrhosis even though most of the histologic hallmarks of NASH are not present in CC.49-51 Patients with CC have a prevalence of diabetes and obesity similar to that of patients with NASH, and a significantly higher prevalence than in patients with cirrhosis from viral and autoimmune disease.50 Patients with CC also have a significantly higher prevalence of diabetes and

obesity than Selleck LY2157299 age and sex matched patients with cirrhosis of well-defined etiology.51 The histologic findings of NASH, fatty deposition, and necroinflammation may disappear when the disease progresses to cirrhosis.51-53 These findings make a definitive diagnosis of NASH difficult when patients present with advanced disease, although the significant association between diabetes, obesity, and CC is very convincing. In addition, patients who undergo liver transplantation for CC frequently develop NAFLD and NASH after transplant. One study demonstrated that 25% of patients developed NAFLD and 16% showed histological evidence of NASH within 26 months of transplant.54 A large proportion of CC, therefore, likely represents end-stage NASH. Multiple retrospective studies have Mannose-binding protein-associated serine protease been done evaluating HCC in the setting of CC,

which support the notion that NASH accounts for a large proportion of CC and can progress to HCC.42, 49, 55, 56 In 2002, Bugianesi et al. reviewed 641 patients with HCC.49 A total of 6.9% of the 641 patients developed HCC in the setting of CC, and these patients were compared to patients with HCC from HCV-related cirrhosis, hepatitis B virus (HBV)-related cirrhosis, and alcoholic cirrhosis.49 Analysis from this comparison confirmed that features associated with NASH, including obesity, diabetes, dyslipidemia, elevated glucose, and insulin resistance, were all significantly associated with CC.49 Another review of a little more than 100 patients with HCC found a much higher prevalence of 29% with underlying CC.55 This study confirms the significant association of obesity, diabetes, and hypertriglyceridemia with CC when compared to other causes of liver disease.55 In this review, 20% of patients in the cryptogenic liver disease group had evidence of NASH on liver biopsies prior to developing HCC, whereas half of the patients with CC had prior NASH or suspected NAFLD. The authors concluded that NAFLD was the underlying liver disease in 13% of the patients with HCC.

Comments are closed.